文献速递乳腺MR

乳腺癌新辅助化疗后病理反应评估系统的比较:与MRI特征计算机辅助诊断的相关性

Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features.
PubMed 文献 · AJR Am J Roentgenol · 2019-06-25

回顾性纳入223例完成新辅助化疗的乳腺癌女性,于术前前后行DCE-MRI,测量6项MRI特征并与Miller-Payne分级、RCB分级及乳腺内RCB指数相关分析;乳腺内RCB指数与MRI特征变化相关性最强,血管体积缩小率相关性最佳。

要点

  • DCE-MRI血管体积缩小率与病理反应相关性最佳(r=-0.75)。
  • 乳腺内RCB指数与MRI特征变化的相关性强于Miller-Payne和RCB分级。
  • 6项MRI特征变化均与三种病理评估系统显著相关。

核心结论

  • 乳腺内RCB指数与DCE-MRI特征变化相关性最好,MRI测量的血管体积缩小率与病理肿瘤反应相关性最佳。

研究设计与样本

  • 回顾性研究,纳入223例女性(平均年龄47.2岁,范围31-71岁),2015年1月至12月在新辅助化疗前后、根治术前接受DCE-MRI,测量6项MRI特征并与Miller-Payne分级、RCB分级及乳腺内RCB指数相关。

关键影像表现/征象

  • 测量6项MRI特征:肿瘤大小、血管体积、峰值强化、持续强化成分、平台强化成分和廓清强化成分。
  • 所有6项MRI特征与乳腺内RCB指数相关性最强(r=-0.75至-0.51,p<0.001)。
  • 与Miller-Payne分级相关性次之(r=0.47-0.72,p<0.001),与RCB分级相关性再次(r=-0.58至-0.41,p<0.001)。

诊断标准与关键数值

  • 乳腺内RCB指数与血管体积缩小率相关性最强(r=-0.75,p<0.001)。
  • 与最大径缩小率相关性次之(r=-0.69,p<0.001),峰值强化缩小率(r=-0.67,p<0.001),廓清成分缩小率(r=-0.60,p<0.001),平台成分缩小率(r=-0.59,p<0.001),持续成分缩小率(r=-0.51,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The objective of our study was to compare pathologic response assessment systems with dynamic contrast-enhanced MRI (DCE-MRI) features and evaluate the predictive performance of DCE-MRI features relative to different pathologic response assessment systems after neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS. This retrospective study included 223 women (mean age, 47.2 years; age range, 31-71 years) who underwent DCE-MRI before and after completing NAC before definitive surgery between January and December 2015. Six MRI features (i.e., tumor size; angio volume; peak enhancement; and persistent, plateau, and washout enhancing components) were measured and correlated with the Miller-Payne grading system, residual cancer burden (RCB) class, and modified in-breast RCB index. Percentage changes in MRI features were correlated with pathologic assessment systems using the Spearman rank correlation test; ROC curves were analyzed to predict pathologic outcomes. RESULTS. All six MRI features correlated most strongly with the in-breast RCB index (r = -0.75 to -0.51, p < 0.001) followed by the Miller-Payne system (r = 0.47-0.72, p < 0.001) and RCB class (r = -0.58 to -0.41, p < 0.001). The in-breast RCB index correlated most strongly with the angio volume reduction rate (r = -0.75, p < 0.001) followed by maximum diameter (r = -0.69, p < 0.001), peak enhancement (r = -0.67, p < 0.001), washout component (r = -0.60, p < 0.001), plateau component (r = -0.59, p < 0.001), and persistent component (r = -0.51, p < 0.001). CONCLUSION. The in-breast RCB index correlated best with changes in DCE-MRI features, and the MRI-measured angio volume reduction rate correlated best with pathologic tumor responses.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Choi WJ, Kim HH, Cha JH, et al. Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features. AJR Am J Roentgenol. 2019. PMID: 31237439. doi:10.2214/AJR.18.21016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。